Cargando…
Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
Autores principales: | Alcami, Jose, Coiras, Mayte, Lopez-Huertas, Maria Rosa, Perez-Olmeda, Mayte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316095/ http://dx.doi.org/10.1186/1742-4690-7-S1-I15 |
Ejemplares similares
-
Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012) -
Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012) -
The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017) -
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IκBα and enhances HIV-1 replication in human T lymphocytes
por: Coiras, Mayte, et al.
Publicado: (2008) -
Basal shuttle of NF-κB/IκBα in resting T lymphocytes regulates HIV-1 LTR dependent expression
por: Coiras, Mayte, et al.
Publicado: (2007)